Dr. Kurlansky explains significance of final Momentum 3 results (HeartMate III LVAD)

http://columbiasurgery.org/lvad

Dr. Paul Kurlansky, Associate Director of the Center for Innovation and Outcomes Research, explains the significance of the final Momentum 3 trial—HeartMate 3, the magnetically levitated pump (LVAD) for people with heart failure, showed a big reduction in clotting over previous LVADs. #ACC19

Видео Dr. Kurlansky explains significance of final Momentum 3 results (HeartMate III LVAD) канала Columbia University Department of Surgery